Sonu Kumar

Real‐world re‐treatment outcomes of direct‐acting antiviral therapy failure in patients with chronic hepatitis C

A. Anand, Ramesh Kumar, Shalimar, 2021, Journal of medical virology.

Oseltamivir analogs with potent anti-influenza virus activity.

Poonam, B. Rathi, P. Kempaiah, 2020, Drug discovery today.

Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases

A. Saraya, C. Das, Shalimar, 2021, Frontiers in Cellular and Infection Microbiology.

Fecal Microbiota Transplantation in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients: A Pilot Study

Ramesh Kumar, A. Chauhan, Shalimar, 2020, Digestive Diseases and Sciences.

Evaluation of the cell-free DNA integrity index as a liquid biopsy marker to differentiate hepatocellular carcinoma from chronic liver disease

A. Saraya, S. Gamanagatti, P. Vanamail, 2022, Frontiers in Molecular Biosciences.

Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection

V. Ravichandiran, S. Sukla, Sonu Kumar, 2022, 3 Biotech.

Prognostic and Therapeutic Potentials of OncomiRs Modulating mTOR Pathways in Virus-Associated Hepatocellular Carcinoma

A. Saraya, V. Sreenivas, S. Gamanagatti, 2021, Frontiers in Oncology.

Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma

A. Saraya, S. Gamanagatti, N. Dash, 2023, Frontiers in genetics.